Kyle A Arsenault

Summary

Publications

  1. doi Direct thrombin inhibitors in cardiovascular disease
    Kyle A Arsenault
    Michael G DeGroote School of Medicine, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada
    Nat Rev Cardiol 9:402-14. 2012
  2. doi Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial
    Kyle A Arsenault
    McMaster University Michael G DeGroote School of Medicine, Hamilton, Ontario, Canada
    J Thorac Cardiovasc Surg 144:944-950.e3. 2012
  3. doi Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery
    Kyle A Arsenault
    Department of Surgery, McMaster University, Hamilton, Canada
    Cochrane Database Syst Rev 1:CD003611. 2013

Detail Information

Publications3

  1. doi Direct thrombin inhibitors in cardiovascular disease
    Kyle A Arsenault
    Michael G DeGroote School of Medicine, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada
    Nat Rev Cardiol 9:402-14. 2012
    ....
  2. doi Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial
    Kyle A Arsenault
    McMaster University Michael G DeGroote School of Medicine, Hamilton, Ontario, Canada
    J Thorac Cardiovasc Surg 144:944-950.e3. 2012
    ..To compare the potency, reversibility, and perioperative bleeding risk of Hepalean with those of PPC heparin...
  3. doi Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery
    Kyle A Arsenault
    Department of Surgery, McMaster University, Hamilton, Canada
    Cochrane Database Syst Rev 1:CD003611. 2013
    ..We conducted an update to a 2004 Cochrane systematic review and meta-analysis of the literature to gain a better understanding of the effectiveness of these interventions...